On Assignment, Inc.  

(Public, NYSE:ASGN)   Watch this stock  
Find more results for William R. Hanson´┐Ż
-0.34 (-0.94%)
Aug 28 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range 35.43 - 36.02
52 week 25.98 - 41.49
Open 35.89
Vol / Avg. 298,331.00/444,274.00
Mkt cap 1.90B
P/E 26.45
Div/yield     -
EPS 1.35
Shares 52.64M
Beta 2.69
Inst. own 89%
Oct 27, 2015
Q3 2015 On Assignment Inc Earnings Release (Estimated) - 4:00PM EDT - Add to calendar
Jul 29, 2015
Q2 2015 On Assignment Inc Earnings Call - Webcast
Jul 29, 2015
Q2 2015 On Assignment Inc Earnings Release
Jun 11, 2015
On Assignment Inc Annual Shareholders Meeting
Jun 9, 2015
On Assignment Inc at William Blair Annual Growth Stock Conference
More events from DailyFinance »    

Key stats and ratios

Q2 (Jun '15) 2014
Net profit margin 2.95% 4.25%
Operating margin 6.74% 7.86%
EBITD margin - 9.92%
Return on average assets 3.81% 6.25%
Return on average equity 8.21% 12.40%
Employees 2,700 -
CDP Score - -


26745 Malibu Hills Rd
CALABASAS, CA 91301-5355
United States - Map
+1-818-8787900 (Phone)
+1-302-6555049 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


On Assignment, Inc. is a global provider of professionals in the information technology (IT), engineering and life sciences sectors. The Company matches people into positions for contract, contract-to-hire and direct hire assignments. Its operating segments include Apex, Oxford and Life Sciences Europe. The Apex Segment provides information technology and scientific staffing professionals for contract, contract-to-hire and permanent placement positions. The Oxford Segment provides contract and direct placement services of information technology and engineering professionals in specialized information technology, software and hardware engineering, and mechanical, electrical, validation and telecommunications engineering fields. The Life Sciences Europe Segment provides locally-based contract life science professionals to clients in the biotechnology, pharmaceutical, food and beverage, medical device, personal care, chemical, automotive, educational and environmental industries.

Officers and directors

Jeremy M. Jones Independent Chairman of the Board
Age: 73
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Peter T. Dameris President, Chief Executive Officer, Director
Age: 55
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Edward L. Pierce Chief Financial Officer, Executive Vice President
Age: 58
Bio & Compensation  - Reuters
Randolph C. Blazer President of Apex
Age: 60
Bio & Compensation  - Reuters
Michael J. McGowan Chief Operating Officer; President - Oxford Global Resources
Age: 61
Bio & Compensation  - Reuters
James L. Brill Senior Vice President, Chief Administrative Officer
Age: 63
Bio & Compensation  - Reuters
Theodore S. Hanson Chief Financial Officer, Apex Systems and President, Lab Support division
Age: 46
Bio & Compensation  - Reuters
William E. Brock Independent Director
Age: 84
Bio & Compensation  - Reuters
Brian T. Callaghan Independent Director
Age: 44
Bio & Compensation  - Reuters
Jonathan S. Holman Independent Director
Age: 70
Bio & Compensation  - Reuters